Hetty E. Carraway, MD, MBA, FACP

Director, Leukemia Program

Vice Chair, Strategy and Enterprise Development

Professor of Medicine

Hematologic Oncology and Blood Disorders

Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

Dr. Hetty Caraway serves as the Director of the Leukemia Program and the Vice Chair of Strategy and Enterprise Development at the Taussig Cancer Institute at Cleveland Clinic. She received her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts. She completed her internship and residency in Internal Medicine, and her Hematology-Medical Oncology fellowship at Johns Hopkins University in Baltimore, Maryland. In addition to her medical training, Dr. Carraway earned an MBA from the Carey Business School at Johns Hopkins University in the Business of Health. She is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Carraway is an active member of numerous professional organizations including the American Society of Hematology (ASH), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Southwest Oncology Group (SWOG), and the America College of Physicians among others. She serves as the Chair of the Committee on Training at ASH.  Dr. Carraway has co-authored numerous peer-­reviewed publications, review articles, editorials, abstracts and book chapters. She is nationally sought for her expertise in hematologic malignancies (MDS/MPN, AML and ALL as well as bone marrow disorders). Dr. Carraway’s research focuses on Phase 1 and 2 clinical trials for the treatment of acute leukemias and myeloid neoplasms.